Predictions
Formycon AG
Start price
Target price
Perf. (%)
€67.40
07.02.21
07.02.21
€80.00
07.02.22
07.02.22
-20.03%
08.02.22
08.02.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
Low dividend yield expected
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€33.80
02.02.21
02.02.21
€30.00
16.02.21
16.02.21
0.27%
02.02.21
02.02.21
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€36.24
01.02.21
01.02.21
€40.00
01.02.22
01.02.22
1.56%
01.02.22
01.02.22
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€36.17
01.02.21
01.02.21
€26.00
30.06.22
30.06.22
-10.17%
19.05.22
19.05.22
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€37.03
29.01.21
29.01.21
€34.00
29.04.21
29.04.21
-5.94%
08.02.21
08.02.21
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€5.64
27.01.21
27.01.21
€8.00
27.01.22
27.01.22
9.75%
28.09.21
28.09.21
Could be worthwhile Investment >10% per year
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€38.44
27.01.21
27.01.21
€45.00
27.01.22
27.01.22
-4.29%
28.01.22
28.01.22
Could be worthwhile Investment >10% per year
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€67.80
23.01.21
23.01.21
€88.00
23.01.22
23.01.22
-26.99%
24.01.22
24.01.22
Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€71.80
23.01.21
23.01.21
€88.00
23.01.22
23.01.22
-30.36%
24.01.22
24.01.22
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€69.30
21.01.21
21.01.21
-
21.01.22
21.01.22
17.39%
29.06.21
29.06.21
Formycon AG
Start price
Target price
Perf. (%)
€60.40
18.01.21
18.01.21
€80.00
18.01.22
18.01.22
-9.93%
04.10.21
04.10.21
Could be worthwhile Investment >10% per year
Merck KGaA
Start price
Target price
Perf. (%)
€144.55
11.01.21
11.01.21
€145.00
11.01.22
11.01.22
42.10%
12.09.21
12.09.21
Could be very worthwhile Investment >20% year
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€39.13
11.01.21
11.01.21
€50.00
11.01.22
11.01.22
-5.37%
29.01.21
29.01.21
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
Mediclin AG
Start price
Target price
Perf. (%)
€4.36
10.01.21
10.01.21
€6.00
10.01.22
10.01.22
-15.14%
11.01.22
11.01.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€39.22
04.01.21
04.01.21
€75.00
04.01.22
04.01.22
11.33%
05.09.21
05.09.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Stratec SE
Start price
Target price
Perf. (%)
€122.40
30.12.20
30.12.20
€128.00
30.12.21
30.12.21
12.75%
31.12.21
31.12.21
Could be worthwhile Investment >10% per year
Medigene AG
Start price
Target price
Perf. (%)
€3.56
18.12.20
18.12.20
-
18.12.21
18.12.21
8.86%
27.02.21
27.02.21
Innovative
Dependend from some customers or products
Higher risks for its business
Bio-Gate AG
Start price
Target price
Perf. (%)
€4.36
13.12.20
13.12.20
-
13.12.21
13.12.21
-5.96%
10.01.21
10.01.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies